Planchard D - Search Results

1

The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer.

Ross K, Pailler E, Faugeroux V, Taylor M, Oulhen M, Auger N, Planchard D, Soria JC, Lindsay CR, Besse B, Vielh P, Farace F. Ross K, et al. Among authors: planchard d. Expert Rev Mol Diagn. 2015;15(12):1605-29. doi: 10.1586/14737159.2015.1111139. Epub 2015 Nov 13. Expert Rev Mol Diagn. 2015. PMID: 26564313 Review.

2

Uncertain benefit from surgery in patients with lung metastases from breast carcinoma.

Planchard D, Soria JC, Michiels S, Grunenwald D, Validire P, Caliandro R, Girard P, Le Chevalier T. Planchard D, et al. Cancer. 2004 Jan 1;100(1):28-35. doi: 10.1002/cncr.11881. Cancer. 2004. PMID: 14692021 Free article.

3

[Targeting epidermal growth factor receptor in non-small cell lung cancer: current advances and perspectives].

Italiano A, Besse B, Planchard D, Soria JC. Italiano A, et al. Among authors: planchard d. Bull Cancer. 2007;94(7 Suppl):F177-88. Bull Cancer. 2007. PMID: 17964994 Review. French.

4

[Angiogenesis targeting in lung cancers].

Planchard D, Besse B. Planchard D, et al. Bull Cancer. 2007;94(7 Suppl):F217-22. Bull Cancer. 2007. PMID: 17964999 Review. French.

5

Mitogen-activated protein kinase activation in lung adenocarcinoma: a comparative study between ever smokers and never smokers.

Mountzios G, Planchard D, Besse B, Validire P, Girard P, Devisme C, Dimopoulos MA, Soria JC, Fouret P. Mountzios G, et al. Among authors: planchard d. Clin Cancer Res. 2008 Jul 1;14(13):4096-102. doi: 10.1158/1078-0432.CCR-07-4150. Clin Cancer Res. 2008. PMID: 18593986

6

[Towards customized therapy for non small cell lung cancer].

Planchard D, Besse B. Planchard D, et al. Bull Cancer. 2008 Oct;95(10):951-8. doi: 10.1684/bdc.2008.0719. Bull Cancer. 2008. PMID: 19004725 Free article. French.

7

The NER proteins are differentially expressed in ever smokers and in never smokers with lung adenocarcinoma.

Planchard D, Domont J, Taranchon E, Monnet I, Tredaniel J, Caliandro R, Validire P, Besse B, Soria JC, Fouret P. Planchard D, et al. Ann Oncol. 2009 Jul;20(7):1257-63. doi: 10.1093/annonc/mdn785. Epub 2009 Mar 17. Ann Oncol. 2009. PMID: 19297315 Free article.

8

Differential expression of biomarkers in men and women.

Planchard D, Loriot Y, Goubar A, Commo F, Soria JC. Planchard D, et al. Semin Oncol. 2009 Dec;36(6):553-65. doi: 10.1053/j.seminoncol.2009.09.004. Semin Oncol. 2009. PMID: 19995647 Review.

9

[Impact of KRAS in standard treatment of non-small cell lung cancer (NSCLC) patients in 2009: prognostic and predictive value].

Planchard D, Loriot Y, Besse B. Planchard D, et al. Bull Cancer. 2009 Dec;96 Suppl:S57-68. doi: 10.1684/bdc.2009.0997. Bull Cancer. 2009. PMID: 20034871 French.

10

Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumors.

Barlési F, Balleyguier C, Besse B, Bonodeau F, Brenac F, Corneloup O, Dansin E, Ferretti G, Gaubert JY, Gervais R, Lacombe C, Loundou A, Moro-Sibilot D, Planchard D, Scherpereel A, Menu Y. Barlési F, et al. Among authors: planchard d. Ann Oncol. 2010 Aug;21(8):1682-1686. doi: 10.1093/annonc/mdp590. Epub 2010 Jan 11. Ann Oncol. 2010. PMID: 20064831 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

266 results

Search Page